Prosecution Insights
Last updated: October 23, 2026
Application No. 17/768,647

PAINT ADDITIVE, PAINT COMPOSITION, AND COATING LAYER

Non-Final OA §102
Filed
Jan 17, 2024
Priority
Oct 29, 2019 — JP 2019-196466 +1 more
Examiner
ZIMMER, MARC S
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Shin-Etsu Chemical Co., Ltd.
OA Round
2 (Non-Final)
79%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
1254 granted / 1579 resolved
+19.4% vs TC avg
Strong +16% interview lift
Without
With
+16.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
46 currently pending
Career history
1634
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
40.0%
+0.0% vs TC avg
§102
25.7%
-14.3% vs TC avg
§112
24.4%
-15.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1579 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendments/Arguments Predicated on the Examiner’s determination that claims 12 and 13 recited allowable subject matter, claim 8 has been amended to include the limitations of claim 12 while also re-defining the invention as a paint composition instead of a paint additive. Whereas the Examiner agrees that these modifications to claim 8 distinguish it over the teachings of Nakanashi and Deeth, an updated/modified survey of the prior art unearthed another reference that renders unpatentable some of the remaining claims as described supra. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 8-9, 14, 18, 20, 24, and 26 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Suruwatari et al., JP 2009-051984 with a brochure from Shin Etsu profiling product no. KF-6038 and also Aso, U.S. Patent Application Publication No. 2013/0338281 as an evidentiary reference proving that KF-6038 complies with the structural requirements of the claimed paint additive. This reference is directed to an acrylic resin-based antistatic coating comprising the materials outlined in the abstract, a surfactant (D) [0011, 0076-0090], a compound (E) featuring an alkylene oxide chain, and, relevant to the present discussion, a polysiloxane-polyoxyalkylene graft copolymer surfactant [0098], of which KF-6028 and KF-6100 are exemplified (with the latter being utilized in Example 14). The Examiner appreciates that the support disclosures from Shin Etsu and Aso define the structure of KF-6038, as opposed to KF-6028. KF-6038 is, according to the combined teachings of paragraphs [0103] and [0243] a graft polysiloxane that contains pendant lauryl (dodecyl) groups, pendant polyether groups conforming with formula (3) of claim 8, and pendant organopolysiloxane chains conforming with formula (4) of claim 8. The second page of the Shin Etsu brochure is suggestive that KF-6038 is comparable in structure to KF-6028 with the only distinction being the absence of long chain alkyl groups (shown in red) being absent from the latter. Thus, one of ordinary skill would infer from these two references that KF-6028 is a graft polysiloxane-polyoxyethylene copolymer featuring both graft polyether- and polysiloxane chains, both chains being linked to the backbone via a divalent hydrocarbon group. As for the weight-average molecular weight limitation, Aso does not address this aspect directly but, rather, says that embodiments of the siloxane copolymer containing substituents as described in formulae (5), (6), and (9), as is the case for KF-6038, have a dynamic viscosity of 500 to 1000 mm2/s and graft copolymers within this viscosity range will inherently possess a Mw consistent with that claimed. As for claim 9, the PSA disclosed in [0115]is said to include acrylic resin of Synthesis Example 1 added in a quantity defined in terms of the amount of solids introduced. The resin is furnished in ethyl acetate assuming that there is no solvent replacement prior to formulating the PSA. The isocyanate component is, likewise, provided as an ethyl acetate solution. Claims 18 and 20 do not place any additional limitations on the makeup of the paint composition but, instead, merely express an intended use. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARC S ZIMMER whose telephone number is (571)272-1096. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. October 1, 2026 /MARC S ZIMMER/Primary Patent Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Jan 17, 2024
Application Filed
Jun 09, 2026
Non-Final Rejection mailed — §102
Sep 08, 2026
Response Filed
Oct 05, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12767857
CURABLE COMPOSITION, ARTICLE, CHECKING METHOD, AND ADHESIVE COMPOSITION
3y 5m to grant Granted Oct 20, 2026
Patent 12767821
CURABLE COMPOSITION, AND CURED PRODUCT
3y 3m to grant Granted Oct 20, 2026
Patent 12767867
TWO-COMPONENT CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF
3y 1m to grant Granted Oct 20, 2026
Patent 12753311
CROSSLINKABLE COMPOSITIONS BASED ON ORGANOSILICON COMPOUNDS
4y 2m to grant Granted Oct 06, 2026
Patent 12753194
TRIAZINE SILANE COMPOUND AND ITS USAGE AS ADHESION PROMOTOR
3y 0m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
79%
Grant Probability
96%
With Interview (+16.1%)
2y 5m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1579 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month